Amedeo Smart

Free Medical Literature Service


 

Amedeo

Liver Transplantation

  Free Subscription

01.04.2024

1 Am Surg
1 Clin Transplant
3 Hepatology
2 J Hepatol
2 PLoS One
1 Radiology
1 Transpl Int
3 Transplant Proc
3 Transplantation



    Am Surg

  1. WALLACE MW, Kastenberg ZJ, Swendiman RA, Eckhauser AW, et al
    Two-Stage Liver Transplantation and Tricuspid Valve Replacement After Blunt Trauma in a Pediatric Patient.
    Am Surg. 2024 Mar 22:31348241241716. doi: 10.1177/00031348241241716.
    >> Share


    Clin Transplant

  2. ENDO Y, Sasaki K, Munir MM, Woldesenbet S, et al
    Effect of the opioid crisis on the liver transplantation donor pool: A national analysis.
    Clin Transplant. 2024;38:e15290.
    >> Share


    Hepatology

  3. CRUZ C, Prado CM, Gillis C, Martindale R, et al
    Nutritional aspects of prehabilitation in adults with cirrhosis awaiting liver transplant.
    Hepatology. 2024 Mar 28. doi: 10.1097/HEP.0000000000000818.
    >> Share

  4. FENG S, Roll GR, Rouhani FJ, Sanchez Fueyo A, et al
    The future of Liver Transplantation.
    Hepatology. 2024 Mar 27. doi: 10.1097/HEP.0000000000000873.
    >> Share

  5. BRAHMANIA M, Kuo A, Tapper EB, Volk M, et al
    Quality measures in pre-liver transplant care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases.
    Hepatology. 2024 Mar 27. doi: 10.1097/HEP.0000000000000870.
    >> Share


    J Hepatol

  6. LI Y, Yang F, Liu K
    Application of Digital Pathology in Liver Transplantation.
    J Hepatol. 2024 Mar 23:S0168-8278(24)00207-1. doi: 10.1016/j.jhep.2024.
    >> Share

  7. LAMARQUE C, Segaux L, Bachellier P, Buchard B, et al
    Evaluation of a delayed liver transplantation strategy for patients with HCC receiving bridging therapy: the DELTA-HCC study.
    J Hepatol. 2024 Mar 21:S0168-8278(24)00202-2. doi: 10.1016/j.jhep.2024.
    >> Share


    PLoS One

  8. WILSON EA, Woodbury A, Williams KM, Coopersmith CM, et al
    OXIDATIVE study: A pilot prospective observational cohort study protocol examining the influence of peri-reperfusion hyperoxemia and immune dysregulation on early allograft dysfunction after orthotopic liver transplantation.
    PLoS One. 2024;19:e0301281.
    >> Share

  9. AZAMAR-LLAMAS D, Arenas-Martinez JS, Olivas-Martinez A, Jimenez JV, et al
    Impact of COVID-19 vaccination on liver transplant recipients. Experience in a reference center in Mexico.
    PLoS One. 2024;19:e0301198.
    >> Share


    Radiology

  10. SUTHAR PP, Virmani S
    Voriconazole-Induced Periostitis in a Patient after Orthotopic Liver Transplantation.
    Radiology. 2024;310:e232902.
    >> Share


    Transpl Int

  11. O'CALLAGHAN JM, Fallon J
    Transplant Trial Watch.
    Transpl Int. 2024;37:12853.
    >> Share


    Transplant Proc

  12. ZHAN HS, Wei L, Liu JY, Xiong HF, et al
    Favorable Outcomes of Liver Transplantation for Hepatopulmonary Syndrome.
    Transplant Proc. 2024 Mar 22:S0041-1345(24)00165.
    >> Share

  13. CHEN IC, Dungca LBP, Lin CC, Yong CC, et al
    Epidemiology and Risk Factors of Early Bacterial Infections After Pediatric Living Donor Liver Transplantation.
    Transplant Proc. 2024 Mar 21:S0041-1345(24)00166.
    >> Share

  14. KOBAYASHI T, Miura K, Ishikawa H, Sakata J, et al
    Malignancy After Living Donor Liver Transplantation.
    Transplant Proc. 2024 Mar 21:S0041-1345(24)00167.
    >> Share


    Transplantation

  15. KIM J, Hong SK, Kim JY, Lee J, et al
    Impact of Preformed Donor-specific Antibodies in Comparison to ABO Incompatibility in Living Donor Liver Transplantation: A Propensity Score-Matched Analysis.
    Transplantation. 2024 Mar 29. doi: 10.1097/TP.0000000000005019.
    >> Share

  16. MIYAKE K, Kim DY, Chau LC, Trudeau S, et al
    Exception Policy Change Increased the Simultaneous Kidney-liver Transplant Probability of Polycystic Disease in the Centers With High Median MELD at Transplantation.
    Transplantation. 2024 Mar 29. doi: 10.1097/TP.0000000000004950.
    >> Share

  17. ISHAQUE T, Beckett J, Gentry S, Garonzik-Wang J, et al
    Waitlist Outcomes for Exception and Non-exception Liver Transplant Candidates in the United States Following Implementation of the Median MELD at Transplant (MMaT)/250-mile Policy.
    Transplantation. 2024 Mar 29. doi: 10.1097/TP.0000000000004957.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016